Results 41 to 50 of about 274,125 (232)

Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause

open access: yesMenopause Review, 2021
During the menopause, a fall in estrogen levels often leads to many unfavorable symptoms, including changes in the vascular and urogenital systems, in mood, and sleep.
Wojciech Pięta, Roman Smolarczyk
doaj   +1 more source

Management of patients with vulvovaginal atrophy and cytological abnormalities

open access: yesГинекология, 2023
The data on managing patients with vulvovaginal atrophy and abnormal cytological results are provided for obstetrician-gynecologists.
Niso M. Nazarova   +5 more
doaj   +1 more source

The use of human adipose-derived stem cells in the treatment of physiological and pathological vulvar dystrophies [PDF]

open access: yes, 2016
“Vulvar dystrophy” is characterized by chronic alterations of vulvar trophism, occurring in both physiological (menopause) and pathological (lichen sclerosus, vulvar graft-versus-host disease) conditions.
CARELLA, SARA   +4 more
core   +12 more sources

Safety and Feasibility of Autologous Micro-Fragmented Adipose Tissue Injections for the Treatment of Vaginal Atrophy, Vulvovaginal Dystrophy, and Stress Urinary Incontinence: An Observational Case Series

open access: yesEuropean Medical Journal Urology, 2020
Objective: Vaginal atrophy, vulvovaginal dystrophy, and stress urinary incontinence (SUI), common conditions in women, have detrimental effects on quality of life.
Laura Stark   +5 more
doaj   +1 more source

Current management of vaginal dryness [PDF]

open access: yesРМЖ. Мать и дитя, 2021
T.V. Tazina1, A.V. Knyazeva2, T.V. Bebneva3,4 1Ryazan State Medical University, Ryazan, Russian Federation 2Regional Clinical Hospital, Ryazan, Russian Federation 3Russian University of Peoples’ Friendship, Moscow, Russian Federation ...
T.V. Tazina, A.V. Knyazeva, T.V. Bebneva
doaj   +2 more sources

Targeted therapy for vulvovaginal atrophy

open access: yesObstetrics and gynecology: News, Opinions, Training
O.P. Vinogradova   +5 more
openaire   +2 more sources

THE EFFECTIVENESS OF PRASTERONE VS PLACEBO THERAPY AS THE VULVOVAGINAL ATROPHY TREATMENT IN MENOPAUSAL WOMEN: META-ANALYSIS STUDY

open access: yesMedical and Health Science Journal, 2020
Background : Vulvovaginal atrophy is a condition that often occurs in menopausal women due to Estrogen decreased. Prasterone (DHEA) is a steroid hormone that can be converted into Estrogen in the target tissue.
Zettira Maulida Prasha, Hari Paraton
doaj   +1 more source

Treatment of symptoms of the menopause: an endocrine society clinical practice guideline [PDF]

open access: yes, 2015
Objective: The objective of this document is to generate a practice guideline for the management and treatment of symptoms of the menopause. Participants: The Treatment of Symptoms of the Menopause Task Force included six experts, a methodologist, and
Davis, Susan R.   +6 more
core   +1 more source

Symptoms and clinic of postmenopausal vulvovaginal atrophy in different stages of postmenopause: A cross sectional study

open access: yesГинекология, 2023
Hypoestrogenism associated with menopause has a strong negative effect on the condition of the vagina and urinary tract, and often leads to the development of genitourinary menopausal syndrome, significantly disrupting the quality of life of women ...
Liana Z. Ziganshina   +3 more
doaj   +1 more source

Pelvic floor muscles training to reduce symptoms and signs of vulvovaginal atrophy : a case study [PDF]

open access: yes, 2016
Objective: Vulvovaginal atrophy (VVA), caused by decreased levels of estrogen, is a common problem in aging women. Main symptoms of VVA are vaginal dryness and dyspareunia.
Dumoulin, Chantale   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy